Lupin announced that its alliance partner has obtained two approvals from the US Food and Drug Administration (USFDA).
The USFDA has granted the final approval to Caplin Steriles, a partner of Lupin, to market its generic version of Zemuron Bromide Injection, 50 mg/5 ml and 100 mg/10 m,l produced by Organon USA Inc.
Caplin Steriles obtained this approval through its abbreviated new drug application (ANDA) for Rocuronium Bromide Injection, 10mg/ml, which will be available in 5 ml and 10 ml multi-dose vials.
In the United States, Rocuronium Bromide Injection recorded an annual sale of around $53 million.
Furthermore, Lupin's partner Caplin Steriles has also received the final approval from the FDA for its Thiamine Hydrochloride Injection USP, 200 mg/2 ml (100 mg/ml) in multiple-dose vials.
This approval allows Caplin Steriles to introduce a therapeutically equivalent version of Fresenius Kabi USA LLC's Thiamine Hydrochloride Injection USP, 200 mg/2 ml (100mg/ml).
In the United States, sales of Thiamine Hydrochloride Injection USP amounted to roughly $36 million on an annual basis.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.